Medication - Medika Life

CATEGORIES

Medication

AI Presents Dangers That Hide With Incredible Ease

Pat Farrell PhD - November 16, 2025

SUICIDE: IS AI RESPONSIBLE?

Christi Taylor-Jones - October 12, 2025

The Trauma of Witnessing Charlie Kirk’s Murder and PTSD

Pat Farrell PhD - September 14, 2025

Beyond Stereotypes: The Exceptional Abilities That Make Autistic Minds Invaluable

Pat Farrell PhD - June 1, 2025

LATEST

Research Critique

The MDMA-Assisted Therapy for PTSD Study. What You’ll Get Wrong

James Coyne - May 25, 2021

News and Views

Is the New York Times a Shill for Promoters of Psychedelics?

James Coyne - May 18, 2021

Mental Health

Blaming the Psychiatric Patient When It’s a Drug-Genetic Interaction

Medika Life - February 26, 2021

For Practitioners

Psilocybin as an Antidepressant for Cancer Patients Who Are Not Depressed

James Coyne - December 14, 2020

News and Views

How Dare You Criticize Psychiatrists Who Praise Studies of Psychedelics As Antidepressants?

James Coyne - December 14, 2020

Clinical Trials

First Drug Synthesized by AI Goes into Clinical Trials

Dr Sohail Merchant - November 18, 2020

Editors Choice

Do Medications Have Psychiatric Side Effects?

Pat Farrell PhD - October 6, 2020

Mental Health

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life - August 12, 2020

1 2 34Page 4 of 4

TRENDING

The 50 Most Influential Leaders in Pharmacy 2022 Awards

Medika Life - January 9, 2023

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life - August 12, 2020

FDA Approval of New Drug for Alzheimer’s Offers Hope

Dr Jeff Livingston - June 8, 2021

Exponential Innovation: Disrupting The Disruptor

John Nosta - January 5, 2022

The Power of Lifestyle Choices – The Dose of Truth in “Heal Thyself”

John Whyte MD - April 24, 2022

Do Medications Have Psychiatric Side Effects?

Pat Farrell PhD - October 6, 2020

Psilocybin as an Antidepressant for Cancer Patients Who Are Not Depressed

James Coyne - December 14, 2020

How Dare You Criticize Psychiatrists Who Praise Studies of Psychedelics As Antidepressants?

James Coyne - December 14, 2020

Weight Management During Fertility Treatment: A Challenge But Not a Lost Cause

Katherine Saunders, MD - March 1, 2023

Does Botox Drop Anxiety?

Michael Hunter, MD - December 23, 2021

EDITORS CHOICE

AI Presents Dangers That Hide With Incredible Ease

Pat Farrell PhD - November 16, 2025

Artificial intelligence, aka AI, has become so advanced that it might be difficult to know whether you are speaking to a live person or...

Beyond Stereotypes: The Exceptional Abilities That Make Autistic Minds Invaluable

Pat Farrell PhD - June 1, 2025

According to The Lancet (in 2021), there were 61.8 million people on the autism spectrum in the world, which is equivalent to 1 out...

How Suboxone Set Me Free From Opiate Addiction

Macarthur Medical Center - June 2, 2021

A pregnant patient shares her journey to overcome opiate addiction to hydrocodone by starting Suboxone.

New National Survey of People Living with Bipolar I Disorder Provides Insights Into Disease-Related Challenges and the Treatment Journey

Medika Life - January 12, 2022

Respondents Reported Physical and Psychosocial Impacts of Living with Bipolar I Disorder and Side Effects of Medications Used to Treat the Disease More Than...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories